Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Curis
Curis is a drug development company that is committed to leveraging its “signaling pathway” drug technologies to seek to create new targeted small molecule drug candidates for cancer. Earlier this month shares of Curis surged following a presentation at a cancer conference in Orlando. Investor interest centers on promising data showing that Curis’ technology platform may have use in battling a wide variety of different cancers.
The Company expects to end ... (see research report)
Subscribe to News Feeds